A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours
Description
This first-in-human study evaluates safety, tolerability and distribution of \[225Ac\] FPI-1966, \[111In\]-FPI-1967, and vofatamab in patients with FGFR3-expressing solid tumors.